APA

Sakurama K., Noma K., Takaoka M., Tomono Y., Watanabe N., Hatakeyama S., Ohmori O., Hirota S., Motoki T., Shirakawa Y., Yamatsuji T., Haisa M., Matsuoka J., Tanaka N. & Naomoto Y. (20090219). Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor. : Molecular cancer therapeutics.

Chicago

Sakurama Kazufumi, Noma Kazuhiro, Takaoka Munenori, Tomono Yasuko, Watanabe Nobuyuki, Hatakeyama Shinji, Ohmori Osamu, Hirota Seiichi, Motoki Takayuki, Shirakawa Yasuhiro, Yamatsuji Tomoki, Haisa Minoru, Matsuoka Junji, Tanaka Noriaki and Naomoto Yoshio. 20090219. Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor. : Molecular cancer therapeutics.

Harvard

Sakurama K., Noma K., Takaoka M., Tomono Y., Watanabe N., Hatakeyama S., Ohmori O., Hirota S., Motoki T., Shirakawa Y., Yamatsuji T., Haisa M., Matsuoka J., Tanaka N. and Naomoto Y. (20090219). Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor. : Molecular cancer therapeutics.

MLA

Sakurama Kazufumi, Noma Kazuhiro, Takaoka Munenori, Tomono Yasuko, Watanabe Nobuyuki, Hatakeyama Shinji, Ohmori Osamu, Hirota Seiichi, Motoki Takayuki, Shirakawa Yasuhiro, Yamatsuji Tomoki, Haisa Minoru, Matsuoka Junji, Tanaka Noriaki and Naomoto Yoshio. Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor. : Molecular cancer therapeutics. 20090219.